Generative AI-Based Health Education for Older Adults With Sarcopenic Obesity
20 agosto 2026 aggiornato da: Taipei Medical University
An Exploration of Health-Promoting Effects of Personalized AI-Generated Multimedia Health Education in Community-Dwelling Older Adults With Sarcopenic Obesity
Sarcopenic obesity is a major public health concern among community-dwelling older adult populations.Encouraging healthy behavior modification through health education emerges as an effective strategy for preventing and treating sarcopenic obesity.
Generative Artificial Intelligence (AI) offers an innovative opportunity to tailor health education for aging populations.
This study aims to explore the effectiveness of Personalized AI-generated Multimedia Health Education in community-dwelling older adults with sarcopenic obesity.
The study comprises two phases, with 280 participants in Study 1 and 180 in Study 2.Study 1, a cluster randomized controlled trial, explores the feasibility, acceptability, and efficacy of different AI-generated multimedia, including images, sounds, and videos.
Study 2 employs a three-armed,individually randomized controlled trial design, creating Personalized AI-generated Multimedia Health Education based on participant preferences.
All materials focus on behavioral risk factors, delivered by social media-based AI chatbots.
The intervention is conducted once a day, five days a week for 12 weeks.Structured questionnaires and objective instruments collect data before and after the intervention.
The study outcome includes behavioral and psychological factors, quality of life, and sarcopenic obesity indicators.
Statistical analyses include descriptive analyses, Chi-square tests, t-tests, One-way analysis of variance, path models, and generalized estimating equations.
This study anticipates that Personalized AI-generated Multimedia Health Education will be a feasible, acceptable, and effective intervention for older adults.
The study results are expected to demonstrate a significant improvement in study outcomes in the experimental group.
Personalized AI-generated multimedia health education could be an easy-to-use,enjoyable, and effective strategy for health promotion and sarcopenic obesity prevention.
Panoramica dello studio
Stato
Non ancora reclutamento
Condizioni
Intervento / Trattamento
Tipo di studio
Interventistico
Iscrizione (Stimato)
500
Fase
- Non applicabile
Contatti e Sedi
Questa sezione fornisce i recapiti di coloro che conducono lo studio e informazioni su dove viene condotto lo studio.
Contatto studio
- Nome: Hsin-Yen Yen, PhD
- Numero di telefono: 27749 886-2-2736-1661
- Email: kenji@tmu.edu.tw
Luoghi di studio
-
-
-
Taipei, Taiwan, 110
- Taipei Medical University
-
Contatto:
- Hsin-Yen Yen, PhD
- Numero di telefono: 27749 886-2-2736-166
- Email: kenji@tmu.edu.tw
-
-
Criteri di partecipazione
I ricercatori cercano persone che corrispondano a una certa descrizione, chiamata criteri di ammissibilità. Alcuni esempi di questi criteri sono le condizioni generali di salute di una persona o trattamenti precedenti.
Criteri di ammissibilità
Età idonea allo studio
- Adulto
- Adulto più anziano
Accetta volontari sani
Sì
Descrizione
Inclusion Criteria:
- . Age: 60 years or older
- . Smartphone ownership with internet connectivity
- . Appendicular fat-free mass (AFFM) calculated by the equation: AFFM = 14.529 + (17.989 * height)+ (0.1307 * fat mass). The cut-off value corresponds to a residual ≤ 3.4 in the equation
- . Ability to read, listen, and understand health education materials with normal cognitive function (MMSE score ≥ 25) and normal sensory function.
Exclusion Criteria:
- . Functional dependency
- . Current residence in long-term care facilities or hospitals
- . Presence of serious diagnosed diseases, disabilities, or mental health issues requiring medical treatment that might influence the study process.
Piano di studio
Questa sezione fornisce i dettagli del piano di studio, compreso il modo in cui lo studio è progettato e ciò che lo studio sta misurando.
Come è strutturato lo studio?
Dettagli di progettazione
- Scopo principale: Prevenzione
- Assegnazione: Randomizzato
- Modello interventistico: Assegnazione parallela
- Mascheramento: Nessuno (etichetta aperta)
Armi e interventi
Gruppo di partecipanti / Arm |
Intervento / Trattamento |
|---|---|
|
Nessun intervento: Nessun intervento
|
|
|
Comparatore attivo: Generative Artificial Intelligence (AI)-based text materials
|
Participants receive a text message regarding the health education topic.
|
|
Sperimentale: Generative AI-based video materials
|
Participants receive a video message , accompanied by AI-generated background music at the beginning and end.
Male avatars are used for PA and SO education, and female avatars are used for HD education.
|
|
Sperimentale: Generative AI-based images materials
|
Participants receive one Gen-AI-generated image concerning the health education topic, formatted as a health poster.
|
|
Sperimentale: Generative AI-based voice materials
|
Participants receive a podcast-style voice message regarding the health education topic.
The recording incorporates AI-generated background voice.
Male voices are utilized for physical activity (PA) education, while female voices are used for healthy diet (HD) and sarcopenic obesity (SO) education.
|
|
Nessun intervento: Comparator Group
|
|
|
Sperimentale: Non-Personalized Gen-AI MHE
|
Participants receive non-personalized multimodal health education generated by generative AI.
|
|
Sperimentale: Personalized Gen-AI MHE
|
Participants receive personalized multimodal health education tailored through generative AI.
|
Cosa sta misurando lo studio?
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
The Chinese version of the Physical Activity Scale for the Elderly
Lasso di tempo: Baseline, midpoint (the 6th week), and post-intervention (the 13rd week)
|
This questionnaire consists of 12 items assessing physical activity (PA) over the past 7 days, including leisure-time, household, and occupational activities.
Total, light-, moderate-, and vigorous-intensity PA can be calculated in metabolic equivalents of task-minutes per week (MET-min/week).
|
Baseline, midpoint (the 6th week), and post-intervention (the 13rd week)
|
|
General Dietary Behavior Inventory
Lasso di tempo: Baseline, midpoint (the 6th week), and post-intervention (the 13rd week)
|
A total of 16 items measure participants' healthy behaviors using a 5-point bipolar scale.The score of each item is summed up to a total score, with a higher score representing healthier dietary behavior.
|
Baseline, midpoint (the 6th week), and post-intervention (the 13rd week)
|
|
The skeletal muscle index (SMI)
Lasso di tempo: Baseline, midpoint (the 6th week), and post-intervention (the 13rd week)
|
A body composition analyzer using bioelectrical impedance analysis technology is conducted.
A higher score (kg/m2) of the skeletal muscle index (SMI) indicates greater muscle mass for sarcopenic indicators.
|
Baseline, midpoint (the 6th week), and post-intervention (the 13rd week)
|
|
Muscle Strength
Lasso di tempo: Baseline, midpoint (the 6th week), and post-intervention (the 13rd week)
|
Muscle strength is assessed using a handheld grip device (SANKA, Japan).
Participants are asked to stand, allow the wrist and arm of the dominant hand to hang straight down, and maintain maximum strength for more than 3 seconds.
This measurement is repeated three times, and the maximum value (kg) is used as the muscle strength.
|
Baseline, midpoint (the 6th week), and post-intervention (the 13rd week)
|
Misure di risultato secondarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
The Health-Promoting Lifestyle Profile II
Lasso di tempo: Baseline, midpoint (the 6th week), and post-intervention (the 13rd week)
|
The Health-Promoting Lifestyle Profile II consists of 29 items measuring participants' engagement in healthy lifestyles.
A 4-point Likert scale is used (1 never, 2 sometimes, 3 frequently, and 4 regularly).
|
Baseline, midpoint (the 6th week), and post-intervention (the 13rd week)
|
|
World Health Organization (WHO)- Quality of Life Scale
Lasso di tempo: Baseline, midpoint (the 6th week), and post-intervention (the 13rd week)
|
A shorter version with 28 questions.
The scale evaluates various aspects of life, including physical health, psychological state, social relationships, and environmental factors, scored between 1 and 5.
|
Baseline, midpoint (the 6th week), and post-intervention (the 13rd week)
|
Collaboratori e investigatori
Qui è dove troverai le persone e le organizzazioni coinvolte in questo studio.
Sponsor
Studiare le date dei record
Queste date tengono traccia dell'avanzamento della registrazione dello studio e dell'invio dei risultati di sintesi a ClinicalTrials.gov. I record degli studi e i risultati riportati vengono esaminati dalla National Library of Medicine (NLM) per assicurarsi che soddisfino specifici standard di controllo della qualità prima di essere pubblicati sul sito Web pubblico.
Studia le date principali
Inizio studio (Stimato)
1 ottobre 2026
Completamento primario (Stimato)
31 dicembre 2029
Completamento dello studio (Stimato)
31 dicembre 2029
Date di iscrizione allo studio
Primo inviato
16 agosto 2026
Primo inviato che soddisfa i criteri di controllo qualità
20 agosto 2026
Primo Inserito (Effettivo)
24 agosto 2026
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Effettivo)
24 agosto 2026
Ultimo aggiornamento inviato che soddisfa i criteri QC
20 agosto 2026
Ultimo verificato
1 gennaio 2026
Maggiori informazioni
Termini relativi a questo studio
Altri numeri di identificazione dello studio
- N202404120
Informazioni su farmaci e dispositivi, documenti di studio
Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti
No
Studia un dispositivo regolamentato dalla FDA degli Stati Uniti
No
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .